Anticoagulants - The Coagulation Process, Thrombosis And Embolism, Heparin, How It Works, Oral Anticoagulants
blood clotting prevent vessels
Anticoagulants are complex organic or synthetic compounds, often carbohydrates, that help prevent the clotting or coagulation of blood. The most widely used of these is heparin, which blocks the formation of thromboplastin, an important clotting factor in the blood. Most anticoagulants are used for treating existing thromboses (clots that form in blood vessels) to prevent further clotting. Oral anticoagulants, such as warfarin and dicumarol, are effective treatments for venous thromboembolisms (a blockage in a vein caused by a clot), but heparin is usually prescribed for treating the more dangerous arterial thrombosis.
Anticoagulants are often mistakenly referred to as blood thinners. Their real role is not to thin the blood but to inhibit the biochemical series of events that lead to the unnatural coagulation of blood inside unsevered blood vessels, a major cause of stroke and heart attack.
Additional Topics
In 1887, Russian scientist Ivan Pavlov first postulated the existence of natural anticlotting factors in animals and humans. His extensive studies of blood circulation led him to the realization that when blood reaches the lungs, it loses some of its ability to coagulate, a process aided, he believed, by the addition of some anticlotting substance. In 1892, A. Schmidt, the father of the enzymatic …
The first effective anticoagulant agent was discovered in 1916 by a medical student, who isolated a specific coagulation inhibitor from the liver of a dog. This substance, known as heparin because it is found in high concentrations in the liver, could not be widely produced until 1933, when Canadian scientists began extracting the substance from the lungs of cattle. In 1937, researchers began usin…
Heparin works by inhibiting or inactivating the three major clotting factors—thrombin, thromboplastin, and prothrombin. It slows the process of thromboplastin synthesis, decelerates the conversion of prothrombin to thrombin, and inhibits the effects of thrombin on fibrinogen, blocking its conversion to fibrin. The agent also causes an increase in the number of negatively charged ions in the…
The development of oral anticoagulants can be linked directly to a widespread cattle epidemic in the United States and Canada during the mid-1920s. A scientist traced the cause of this outbreak to the cattle feed, a fodder containing spoiled sweet clover, which caused the cattle to bleed to death internally. Mixing alfalfa, a food rich in vitamin K, into the fodder seemed to prevent the disease. I…
Citing this material
Please include a link to this page if you have found this material useful for research or writing a related article. Content on this website is from high-quality, licensed material originally published in print form. You can always be sure you're reading unbiased, factual, and accurate information.
Highlight the text below, right-click, and select “copy”. Paste the link into your website, email, or any other HTML document.
User Comments